CIK 0001672688
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Absci Corp
Sign in to watch- Ticker
- ABSI
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 853383487
- Phone
- +1 360-949-1041
- Business address
- 18105 SE MILL PLAIN BLVD, VANCOUVER, WA, 98683
- Former names
- AbSci, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-01 | Korman Sarah Chief Legal Officer | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2022-07-01 | Korman Sarah General Counsel | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-02-21 | Korman Sarah General Counsel | Grant or award · Stock Option (right to buy) | +160,000 | 160,000 | ||
| 2022-02-09 | Korman Sarah General Counsel | Purchase | +4,250 | $7.96 | $34K | 14,250 |
| 2022-01-07 | Korman Sarah General Counsel | Grant or award · Stock Option (right to buy) | +437,172 | 437,172 | ||
| 2021-07-26 | Korman Sarah General Counsel | Purchase | +10,000 | $16.00 | $160K | 10,000 |
Page 1 of 1 · 6 trades